| Targeting CAG repeat RNAs reduces Huntington’s disease phenotype independently of huntingtin levels L Rué, M Bañez-Coronel, J Creus-Muncunill, A Giralt, R Alcalá-Vida, ... The Journal of clinical investigation 126 (11), 4319-4330, 2016 | 82 | 2016 |
| Neuron type‐specific increase in lamin B1 contributes to nuclear dysfunction in Huntington’s disease R Alcalá‐Vida, M Garcia‐Forn, C Castany‐Pladevall, J Creus‐Muncunill, ... EMBO Molecular Medicine 13 (2), e12105, 2021 | 38 | 2021 |
| Altered m6A RNA methylation contributes to hippocampal memory deficits in Huntington’s disease mice A Pupak, A Singh, A Sancho-Balsells, R Alcalá-Vida, M Espina, A Giralt, ... Cellular and Molecular Life Sciences 79 (8), 416, 2022 | 36 | 2022 |
| Age-related and disease locus-specific mechanisms contribute to early remodelling of chromatin structure in Huntington’s disease mice R Alcalá-Vida, J Seguin, C Lotz, AM Molitor, I Irastorza-Azcarate, A Awada, ... Nature communications 12 (1), 364, 2021 | 24 | 2021 |
| Epigenetic mechanisms underlying enhancer modulation of neuronal identity, neuronal activity and neurodegeneration R Alcalà-Vida, A Awada, AL Boutillier, K Merienne Neurobiology of Disease 147, 105155, 2021 | 22 | 2021 |
| Early down-regulation of PKCδ as a pro-survival mechanism in Huntington’s disease L Rue, R Alcala-Vida, G Lopez-Soop, J Creus-Muncunill, J Alberch, ... Neuromolecular medicine 16, 25-37, 2014 | 20 | 2014 |
| Chelerythrine promotes Ca2+-dependent calpain activation in neuronal cells in a PKC-independent manner A Saavedra, S Fernández-García, S Cases, M Puigdellívol, R Alcalá-Vida, ... Biochimica et Biophysica Acta (BBA)-General Subjects 1861 (4), 922-935, 2017 | 16 | 2017 |
| Hepatic primary and secondary cholesterol deposition and damage in Niemann-Pick disease M Bosch, A Fajardo, R Alcalá-Vida, A Fernández-Vidal, F Tebar, C Enrich, ... The American journal of pathology 186 (3), 517-523, 2016 | 15 | 2016 |
| Increased levels of rictor prevent mutant huntingtin-induced neuronal degeneration J Creus-Muncunill, L Rué, R Alcalá-Vida, R Badillos-Rodríguez, ... Molecular Neurobiology 55, 7728-7742, 2018 | 12 | 2018 |
| Altered activity-regulated H3K9 acetylation at TGF-beta signaling genes during egocentric memory in Huntington’s disease R Alcalá-Vida, C Lotz, B Brulé, J Seguin, C Decraene, A Awada, ... Progress in Neurobiology 219, 102363, 2022 | 5 | 2022 |
| Hippocampal cannabinoid 1 receptors are modulated following cocaine self-administration in male rats D de Sa Nogueira, R Bourdy, R Alcala-Vida, D Filliol, V Andry, Y Goumon, ... Molecular Neurobiology 59 (3), 1896-1911, 2022 | 5 | 2022 |
| Mutant FUS induces chromatin reorganization in the hippocampus and alters memory processes L Tzeplaeff, J Seguin, S Le Gras, S Megat, B Cosquer, D Plassard, ... Progress in Neurobiology, 102483, 2023 | 3 | 2023 |
| Dysregulated expression of cholesterol biosynthetic genes in Alzheimer's disease alters epigenomic signatures of hippocampal neurons I Paiva, J Seguin, I Grgurina, AK Singh, B Cosquer, D Plassard, ... Neurobiology of Disease 198, 106538, 2024 | 2 | 2024 |
| Keep calm and carry H3K27me1 off R Alcalá-Vida, A Barco Neuron 112 (17), 2829-2832, 2024 | | 2024 |
| The AMPA receptor positive allosteric modulator S 47445 rescues in vivo CA3-CA1 long-term potentiation and structural synaptic changes in old mice A Giralt Torroella, MÁ Gómez Climent, R Alcalá Vida, S Bretin, D Bertrand, ... Neuropharmacology, 2017, vol. 123, p. 395-409, 2017 | | 2017 |
